top
Search terms
Results 1 - 2 of 2 - ordered by :
Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program
Ejhf

Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) ...

European Journal of Heart Failure, Allen, Larry A., Felker, G. Michael, Pocock, Stuart, McMurray, John J.V., Pfeffer, Marc A., Swedberg, Karl, Wang, Duolao, Yusuf, Salim, Michelson, Eric L., Granger, ...

Date : 01/02/2009 Item size : 166647 bytes
Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program
Ejhf

Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) ...

European Journal of Heart Failure, Allen, Larry A., Felker, G. Michael, Pocock, Stuart, McMurray, John J.V., Pfeffer, Marc A., Swedberg, Karl, Wang, Duolao, Yusuf, Salim, Michelson, Eric L., Granger, ...

Date : 01/02/2009 Item size : 169135 bytes